Concepedia

David Bomze

DB

Statistics

Publications

39

Citations

3.2K

H-Index

28

Active since

2015

Affiliations

Tel Aviv University(Current)

University Hospital of Zurich

Kantonsspital St. Gallen

Sheba Medical Center

University of Bern

David Bomze is an author at Tel Aviv University specializing in life sciences, oncology, and immunology.

ORCID

Publications per year

2015–2024

39

Publications

39

Glycolysis-Mediated Changes in Acetyl-CoA and Histone Acetylation Control the Early Differentiation of Embryonic Stem Cells

Arieh Moussaieff, Matthieu Rouleau, Daniel Kitsberg et al. · Cell Metabolism · 2015 · 671 citations · Full text

, , +17

Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer

Fiamma Berner, David Bomze, Stefan Diem et al. · JAMA Oncology · 2019 · 393 citations · Full text

, , +17

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Omar Hasan Ali, Fiamma Berner, David Bomze et al. · European Journal of Cancer · 2018 · 183 citations · Full text

, , +17

Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy

Adam Goldman, Elad Maor, David Bomze et al. · Journal of the American College of Cardiology · 2021 · 150 citations · Full text

, , +16

Long-term culture and expansion of primary human hepatocytes

Gahl Levy, David Bomze, Stefan Heinz et al. · Nature Biotechnology · 2015 · 148 citations

, , +14

1–5 of 39